Explanation:
Treatment should adhere to thetreatment options as in nonpregnant women. The optimal time to perform the procedure during pregnancy is still a matter of debate. It is recommended to delay surgery if possible until after the first trimester to reduce the miscarriage risk—surgery during the second and third trimesters surgery is considered safe. Delay can cause progressive neurologic deterioration and increasing risk of urgent intervention (resection and cesarean section). Due to the significant complications of prematurity (e.g. respiratory diseases, bradycardia, necrotizing enterocolitis, intraventricular hemorrhage, hypoglycemia and feeding problems, sepsis and seizures) iatrogenic preterm birth should be avoided whenever possible by postponing or continuing treatment until a term delivery can be achieved. The decision of performing an elective cesarean section preterm is often based upon the risk of increased intracranial pressure associated with bearing-down efforts during the second stage of labor. Nonetheless, if patients are clinically stable and carefully discussed, and the individual risk of rapid tumor growth has been evaluated, gestational advancement until fetal maturity should be considered, as well as the attempt to have a vaginal delivery. Balance between waiting for fetal maturation and risk of intrauterine death (secondary to maternal death) remains difficult in patients with highly malignant tumors. A recent study summarized long-term data of children after antenatal exposure to chemotherapy (and/or radiotherapy) found a cardiac outcome equal to the general population, and no adverse effects of treatment on the general health and age-appropriate neurocognitive (IQ, attention, behavior, memory) development. Estimations of the absorbed fetal dose were between 0.01 and 0.1 Gy (10-100 mGy) for patients who received whole brain RT by a 3D conformal technique and many of the toxic effects will only be induced above the deterministic threshold of 0.1 Gy. Most studies reporting on the administration of radiotherapy to brain tumors showed that the fetal exposure never exceeded this threshold dose. These radiotherapy schedules are therefore considered safe. Still, proper shielding should always be used to further reduce the fetal dose and it is recommended to discuss treatment with a radiation physicist and to use a phantom to estimate the fetal dose as accurate as possible in order to counsel parents on the potential risks of radiation-induced toxicity.
Ref
Tewari KS, Cappuccini F, Asrat T, et al. Obstetric emergencies precipitated by malignant brain tumors. Am J Obstet
Gynecol 2000;182:1215-21
Verheecke M, Halaska MJ, Lok CA, et al. Primary brain tumours, meningiomas and brain metastases in pregnancy: report on 27 cases and review of literature. Eur J Cancer 2014;50(8):1462-71; Amant F, Van Calsteren K, Halaska MJ, et al.
Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children ged 18 months or older: An observational study. Lancet Oncol 2012;13(3)
Explanation:
Treatment should adhere to thetreatment options as in nonpregnant women. The optimal time to perform the procedure during pregnancy is still a matter of debate. It is recommended to delay surgery if possible until after the first trimester to reduce the miscarriage risk—surgery during the second and third trimesters surgery is considered safe. Delay can cause progressive neurologic deterioration and increasing risk of urgent intervention (resection and cesarean section). Due to the significant complications of prematurity (e.g. respiratory diseases, bradycardia, necrotizing enterocolitis, intraventricular hemorrhage, hypoglycemia and feeding problems, sepsis and seizures) iatrogenic preterm birth should be avoided whenever possible by postponing or continuing treatment until a term delivery can be achieved. The decision of performing an elective cesarean section preterm is often based upon the risk of increased intracranial pressure associated with bearing-down efforts during the second stage of labor. Nonetheless, if patients are clinically stable and carefully discussed, and the individual risk of rapid tumor growth has been evaluated, gestational advancement until fetal maturity should be considered, as well as the attempt to have a vaginal delivery. Balance between waiting for fetal maturation and risk of intrauterine death (secondary to maternal death) remains difficult in patients with highly malignant tumors. A recent study summarized long-term data of children after antenatal exposure to chemotherapy (and/or radiotherapy) found a cardiac outcome equal to the general population, and no adverse effects of treatment on the general health and age-appropriate neurocognitive (IQ, attention, behavior, memory) development. Estimations of the absorbed fetal dose were between 0.01 and 0.1 Gy (10-100 mGy) for patients who received whole brain RT by a 3D conformal technique and many of the toxic effects will only be induced above the deterministic threshold of 0.1 Gy. Most studies reporting on the administration of radiotherapy to brain tumors showed that the fetal exposure never exceeded this threshold dose. These radiotherapy schedules are therefore considered safe. Still, proper shielding should always be used to further reduce the fetal dose and it is recommended to discuss treatment with a radiation physicist and to use a phantom to estimate the fetal dose as accurate as possible in order to counsel parents on the potential risks of radiation-induced toxicity.
Ref
Tewari KS, Cappuccini F, Asrat T, et al. Obstetric emergencies precipitated by malignant brain tumors. Am J Obstet
Gynecol 2000;182:1215-21
Verheecke M, Halaska MJ, Lok CA, et al. Primary brain tumours, meningiomas and brain metastases in pregnancy: report on 27 cases and review of literature. Eur J Cancer 2014;50(8):1462-71; Amant F, Van Calsteren K, Halaska MJ, et al.
Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children ged 18 months or older: An observational study. Lancet Oncol 2012;13(3)